Desai Diwanji advise Sanofi Pasteur in Shanta Biotechnics acquisition | Bar and Bench

Desai Diwanji advise Sanofi Pasteur in Shanta Biotechnics acquisition

Desai & Diwanji continues to strengthen its Mergers and Acquisitions practice, advising on a whopping Rs. 3,748 crore ($781 million) deal. Desai and Diwanji advised French pharma major Sanofi Pasteur in their acquisition of Hyderabad based Shanta Biotechnics.

Sanofi Pasteur acquired Merieux Alliance's French subsidiary, ShanH, which has a 78 percent stake in Shanta Biotechnics. The Desai & Diwanji team comprising Devika Cariappa and Ketaki Gaur were led by Partner Apurva Diwanji.

Category: 

Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
By submitting this form, you accept the Mollom privacy policy.